Norway Country Drug Report 2017

Key statistics

Most recent estimates and data reported

  EU range
  Year Country data Min. Max.
Cannabis
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 6.5 6.5 36.8
Last year prevalence of use - young adults (%) 2015 8.6 0.4 22.1
Last year prevalence of drug use - all adults (%) 2015 4.2 0.3 11.1
All treatment entrants (%) 2015 27 3 71
First-time treatment entrants (%) No data No data 8 79
Quantity of herbal cannabis seized (kg) 2015 255 4 45 816
Number of herbal cannabis seizures 2015 4 411 106 156 984
Quantity of cannabis resin seized (kg) 2015 2 015 1 380 361
Number of cannabis resin seizures 2015 11 394 14 164 760
Potency - herbal (% THC) (minimum and maximum values registered) No data No data 0 46
Potency - resin (% THC) (minimum and maximum values registered) No data No data 0 87.4
Price per gram - herbal (EUR) (minimum and maximum values registered) 2015 11-22 0.6 31.1
Price per gram - resin (EUR) (minimum and maximum values registered) 2015 11-22 0.9 46.6
Cocaine
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 0.9 0.9 4.9
Last year prevalence of use - young adults (%) 2015 2.2 0.2 4
Last year prevalence of drug use - all adults (%) 2015 1 0.1 2.3
All treatment entrants (%) 2015 1 0 37
First-time treatment entrants (%) No data No data 0 40
Quantity of cocaine seized (kg) 2015 85.3 2 21 621
Number of cocaine seizures 2015 1 332 16 38 273
Purity (%) (minimum and maximum values registered) No data No data 0 100
Price per gram (EUR) (minimum and maximum values registered) 2015 89 10 248.5
Amphetamines
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 0.9 0.8 6.5
Last year prevalence of use - young adults (%) 2015 0.3 0.1 3.1
Last year prevalence of drug use - all adults (%) 2015 0.2 0 1.6
All treatment entrants (%) 2015 14 0 70
First-time treatment entrants (%) No data No data 0 75
Quantity of amphetamine seized (kg) 2015 500 0 3 796
Number of amphetamine seizures 2015 5 089 1 10 388
Purity - amphetamine (%) (minimum and maximum values registered) No data No data 0 100
Price per gram - amphetamine (EUR) (minimum and maximum values registered) 2015 22-44 1 139.8
MDMA
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 1 0.5 5.2
Last year prevalence of use - young adults (%) 2015 1.2 0.1 6.6
Last year prevalence of drug use - all adults (%) 2015 0.6 0.1 3.4
All treatment entrants (%) 2015 0 0 2
First-time treatment entrants (%) No data No data 0 2
Quantity of MDMA seized (tablets) 2015 116 353 54 5 673 901
Number of MDMA seizures 2015 1 241 3 5 012
Purity (mg of MDMA base per unit) (minimum and maximum values registered) No data No data 0 293
Price per tablet (EUR) (minimum and maximum values registered) 2015 16-44 0.5 60
Opioids
High-risk opioid use (rate/1 000) 2013 2.7 0.3 8.1
All treatment entrants** (%) 2015 17 4 93
First-time treatment entrants (%) No data No data 2 87
Quantity of heroin seized (kg) 2015 62 0 8 294
Number of heroin seizures 2015 1 178 2 12 271
Purity - heroin (%) (minimum and maximum values registered) No data No data 0 96
Price per gram - heroin (EUR) (minimum and maximum values registered) 2015 89 3.1 214
Newly diagnosed HIV cases related to injecting drug use (cases/ million population, Source: ECDC) 2015 1.5 0 44
HIV prevalence among PWID* (%) 2015 1.9 0 30.9
HCV prevalence among PWID* (%) 2015 60.2 15.7 83.5
Injecting drug use (cases rate/1 000 population) 2014 2.5 0.2 9.2
Drug-induced deaths all adults (cases/million population) 2014 75.6 1.6 102.7
Health and social responses
Syringes distributed through specialised programmes 2015 2 500 192 164 12 314 781
Clients in substitution treatment 2015 7 498 252 168 840
Treatment demand
All clients 2015 5 908 282 124 234
First-time clients No data No data 24 40 390
Drug law offences
Number of reports of offences 2014 48 152 472 411 157
Offences for use/possession 2014 24 671 359 390 843

* PWID, people who inject drugs.
** The percentage of clients in treatment for opioids is a minimum value, not accounting for opioid clients registered as polydrug users.


Norway main page